Related Experiment Video
Updated: Jun 28, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
TP53 gene mutations in canine osteosarcoma
Jolle Kirpensteijn1, Marja Kik, Erik Teske
1Department of Clinical Sciences of Companion Animals and Pathobiology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. j.kirpensteijn@uu.nl
TP53 gene mutations are common in canine osteosarcoma (OS) and are linked to shorter survival times. These TP53 mutations may influence prognosis and should be considered in OS evaluation.
Area of Science:
- Veterinary oncology
- Molecular genetics
- Cancer research
Background:
- Canine osteosarcoma (OS) is an aggressive bone cancer.
- The TP53 gene is a critical tumor suppressor.
- Understanding genetic alterations in canine OS is crucial for prognosis.
Purpose of the Study:
- To investigate the frequency and type of TP53 gene mutations in canine osteosarcoma.
- To evaluate the prognostic significance of TP53 mutations in canine OS.
Main Methods:
- A clinical cohort study involving 59 client-owned dogs with OS.
- Screening of the complete TP53 gene for mutations using polymerase chain reaction and single-strand conformational polymorphism.
- Comparison of clinical outcomes between dogs with and without TP53 mutations.
Main Results:
- TP53 gene mutations were identified in 40.7% of canine OS cases.
- Point mutations were the predominant type of alteration.
- Dogs with TP53-mutated OS exhibited significantly shorter survival times compared to those with normal TP53 expression.
Conclusions:
- TP53 gene mutations are prevalent in canine osteosarcoma.
- TP53 mutations appear to have prognostic value in canine OS.
- Considering TP53 gene status may improve the evaluation and management of canine OS.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

